Next generation sequencing is evolving at a sensational pace and this has led to fantastic output and multiplexing of genomic regulation. It is now possible to study and analyze thousands of RNA Sequences for profiling applications. Small RNA sequencing facilitates the study of isoforms and expression patterns and plays a pivotal role in the discovery of many genetic diseases.
Milton, UK -- (SBWIRE) -- 06/17/2015 -- Small RNA sequencing has become accessible and feasible, and this opened up new opportunities for the discovery of disease causing DNA and identification of novel links that are suspected to be associated with human diseases. CD Genomics provide both basic and advanced bioinformatics analysis with a detailed report and final consultation. The company has a standard predefined procedure for accurate detection of small RNA.
Small RNA sequencing allows researchers to detect non-coding RNA, study variations using single-base resolution, and analyze miRNA without any information about the secondary structure. Small RNA sequencing can be effectively used to investigate the differential expression of small RNA in any given sample. This technology has made those studies possible which could not be imagined just a few years back and has made path breaking advancements in the disciplines of life sciences and clinical diagnostics. The advantages of availing small RNA sequencing services at CD Genomics include:
- Rapid turnaround time
- Accurate results
- Complete quality control
- High-throughput data
- Greater sensitivity
Small RNA sequencing facilitates an accurate measurement of transcripts and aids in the characterization of eukarytone transcriptomes. It is being used in the understanding of transcriptomics and also for quantification of each transcript along with mapping of transcribed areas. The technology is under progressive development and is currently employed for investigating complex transcriptomes since it allows unambiguous mapping and has a dynamic range with high levels of reproducibility for biological replicates. It needs less RNA sample and enables researchers to study transcriptomes in a quantitative manner. Small RNA sequencing is low-cost and generates unprecedented data for several species. It can determine expression patterns more accurately and gives increased depth and coverage. Due to all these advantages, it is fast replacing microarrays in several genome sequencing applications that relate to the dynamics of transcriptomes.
Researchers are now using small RNA sequencing for drug discovery, identification of cancer cells, the discovery of biomarkers and for guiding treatment decisions. CD Genomics proprietary GenSeqTM Technology provides accurate detection and quantification of small RNA sequencing services which include known and novel microRNA, piRNA and several other non-coding RNA, as well as the bioinformatics analysis of the RNA-Seq data.
About CD Genomics
CD Genomics is a leading biotechnology company based in New York offering fast and accurate genome sequencing services at competitive prices. The company provides comprehensive research solutions to educational institutions, government agencies and pharmaceutical companies. To avail their small RNA sequencing services, log on to cd-genomics.com.